Doheny Asset Management /Ca Gilead Sciences, Inc. Transaction History

Doheny Asset Management /Ca

$146 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$63.15 - $72.88 $2.47 Million - $2.86 Million	39,179 New	39,179 $2.69 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $10,990 - $12,463	-150 Reduced 3.08%	4,714 $382,000
Q1 2023 May 16, 2023	BUY	$77.31 - $88.08 $193,275 - $220,200	2,500 Added 105.75%	4,864 $404,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $155,800 - $223,675	-2,500 Reduced 51.4%	2,364 $203,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $15,480 - $17,682	-260 Reduced 5.07%	4,864 $300,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $770,046 - $964,951	-13,295 Reduced 72.18%	5,124 $305,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $254,329 - $288,668	-3,920 Reduced 17.55%	18,419 $1.34 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $794,327 - $867,915	12,515 Added 127.39%	22,339 $1.54 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $156,000 - $177,995	2,600 Added 35.99%	9,824 $635,000
Q4 2020 Feb 26, 2021	SELL	$56.65 - $64.55 $1.21 Million - $1.38 Million	-21,405 Reduced 74.77%	7,224 $421,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $55,890 - $70,272	-900 Reduced 2.3%	38,279 $2.42 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $599,265 - $753,472	-9,650 Reduced 25.21%	28,629 $1.86 Million
Q2 2020 Aug 18, 2020	BUY	$72.34 - $84.0 $763,187 - $886,200	10,550 Added 36.85%	39,179 $3.01 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $493,576 - $542,917	-8,010 Reduced 21.86%	28,629 $1.86 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $581,968 - $642,390	-9,310 Reduced 20.26%	36,639 $2.32 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $309 - $346	5 Added 0.01%	45,949 $3.1 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $1.37 Million - $1.53 Million	21,840 Added 90.61%	45,944 $2.99 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $210,376 - $274,525	-3,475 Reduced 12.6%	24,104 $1.51 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $492,402 - $545,179	6,908 Added 33.42%	27,579 $2.13 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $930,054 - $1.08 Million	-14,335 Reduced 40.95%	20,671 $1.46 Million
Q1 2018 May 17, 2018	BUY	$72.84 - $88.8 $819,814 - $999,444	11,255 Added 47.39%	35,006 $2.64 Million
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $234,439 - $275,198	-3,295 Reduced 12.18%	23,751 $1.7 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.95 Million - $2.31 Million	27,046	27,046 $2.19 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.

Account